Hacker News Reader

You are probably right. We might have to accept less innovation in order to make the products affordable.

We are being asked to make the same hard decisions that each generation before us has made. And we are doing it while being far richer and having a greater repository of knowledge than them. Something's wrong with us if we quit where they preserved in worse conditions.

WHO is far richer, and WHO should pay for it? Are we fine with these companies spending 1/4 of their combined profits and marketing on R & D, as J&J does? At best, this is a remarkably inefficient way to drive innovation.

The largest 10 pharmaceutical companies spent a combined $32.5B more on sales and marketing than R & D. No problem here? People are skipping dosing to stretch their meds further. Some people can't afford meds at all.

Reply on news.ycombinator.com